Many of our high net-worth clients are finding themselves re-evaluating their annual charitable contributions as well as some of their estate planning goals as they concentrate on meeting their future retirement or current income needs. There are always choices, however, that one can make depending on their priorities and resources.
National report - The National Psoriasis Foundation is kicking off their Walk with your Doc program to raise awareness and funds for psoriasis and psoriatic arthritis.
New York - The Skin Cancer Foundation is urging citizens to write to their congressional representatives to request $10 million for melanoma research, according to the foundation.
Would your assets be protected if you were sued? Darrell Aviss of Swiss Guard International walks physicians through a strategy for protecting wealth.
More and more health insurers are publishing quality ratings of individual physicians, but critics argue the programs are inherently flawed.
Dermatology Times presents an interview with Dr James Young, a cardiologist with the Cleveland Clinic, which signed on early with Google Health and was part of its pilot project.
Are you headed to San Francisco this month? Check out our podcast to find the best places to dine, visit and shop!
A St. Louis hospital’s inpatient pediatric atopic dermatitis program brings together dermatology, physical therapy, nursing and other health professionals, as well as a child life specialist (to help with coping skills) - and even volunteers. Pediatric dermatologist Elaine Siegfried, M.D., tells Dermatology Times how she helped to launch the inpatient care concept at Cardinal Glennon Children’s Medical Center, and how it helps patients with severe outbreaks.
Zurich, Switzerland - Roche Holding AG has sealed a deal with Genentech to buy the 44 percent of the company that it doesn't already own for $95 a share, CNNMoney.com reports.
National report - The purchase of Schering-Plough for 41.1 billion in cash and stock has given Merck a dozen experimental drugs that are nearing marketing approval in the U.S., which may pay off before Merck loses patents on medicines with $8 billion in annual sales, Bloomberg.com reports.
San Francisco - Patients presenting with oral ulcers is not an uncommon occurrence, but the precise etiology of these lesions may at times be a source of confusion to the clinician.
Rouen, France ?Patients with toxic epidermal necrolysis (TEN) or Stevens-Johnson syndrome (SJS) commonly experience acute ocular involvement, according to a study published in the Archives of Dermatology.
International report ? International report ? Playing video games excessively can lead to a skin condition dubbed "Playstation palmar hidradenitis," characterized by painful sores that occur due to sweating, according to BBC News.
International report ? Gray hair is caused by a massive build-up of hydrogen peroxide, due to "wear and tear" of hair follicles, which blocks the synthesis of melanin, according to a study published in the FASEB Journal.
Madrid ? Spanish authorities withdrew 76,000 doses of Gardasil (human papillomavirus quadrivalent vaccine, recombinant, Merck) from the market in February after two teenagers who received the vaccine were hospitalized, according to the news agency Agence France-Presse.
National report - Synta Pharmaceuticals has stopped drug trials for a melanoma drug due to serious safety issues, Forbes.com reports.
"Cleveland - The first American to receive a face transplant has gone home from the Cleveland Clinic, and doctors say her recovery has been "astonishing," according to published accounts. "
National report - Busy dermatologists say that new Pharmaceutical Research and Manufacturers Association (PhRMA) give-away guidelines reflect many policies they already had adopted.
National report - Dermatologists won't miss the free pencils, notepads and posh dinners that new Pharmaceutical Research and Manufacturers of America (PhRMA) guidelines prohibit companies from providing, say physicians contacted by Dermatology Times.
National report - The North American Contact Dermatitis Group (NACDG) has named mixed dialkyl thioureas as the 2009 Allergen of the Year, according to Bryan E. Anderson, M.D., associate professor of dermatology at Penn State College of Medicine in Hershey, Pa.
National report - A new prescription product that promotes eyelash growth (Latisse, bimatoprost ophthalmic solution 0.03 percent; Allergan) will benefit cosmetic-minded patients and the dermatologists who serve them, sources say.
Dermatologist Dennis J. Doud, M.D., jumps into things with both feet. His first mountain-climbing experience was Mount Everest; his first marathon, Boston.
In 2008, many Americans were left with a general sense of concern for our economy. The mortgage and credit crisis, presidential election and record federal budget deficits have caused many of our physician clients to believe that taxes will increase.
In our current financial crisis, it's only natural to worry about the safety of our assets, and every business owner or professional with an investment portfolio has some portion of it invested in cash or cash equivalents.
With the economy in the gutter, businesses closing left and right, and hundreds of thousands of Americans being laid off or losing their jobs, owners of medical practices are starting to worry how the slumping economy will affect their practices short- and long-term.
Patient relations experts and practice management consultants often talk about "moments of truth" - those small encounters that can set the tone for the patient's entire experience at a practice.
A new ultrasound-guided fine needle aspiration cytology technique used to extract cells from suspected melanoma-infiltrated sentinel lymph nodes offers a more sophisticated and very accurate clinical assessment of sentinel lymph nodes.
In a recent five-year study involving superficial BCC, daily treatment with imiquimod achieved high-sustained clearance and low-recurrence rates, the study's lead author says.
A recent study indicates that melanoma does not necessarily develop de novo. Banal nevi demonstrating melanocytic aggregates are thought to be the precursors of melanoma.
A recent study shows the cross-linked hyaluronic acid gel filler Juvéderm is associated with smoother, softer results, and achieved high patient satisfaction.
